Literature DB >> 2904255

Pvu II polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Study of Italians.

A Daga1, M Fabbi, T Mattioni, S Bertolini, G Corte.   

Abstract

Familial hypercholesterolemia is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low density lipoprotein (LDL) level. It has been demonstrated that the disease is caused by several different mutations in the LDL receptor gene. Although early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infarction, the available techniques for determining the number of the functional LDL receptor molecules are not sufficiently accurate. The recent isolation of the LDL receptor gene now makes it possible to use restriction fragment length polymorphisms to study the inheritance of the defective allele in families with familial hypercholesterolemia. In the present study, we report the use of a Pvu II restriction fragment length polymorphism to follow the inheritance of familial hypercholesterolemia in a total of 79 patients from 37 different families. This restriction fragment length polymorphism allowed unequivocal diagnosis in 32.5% of the cases. Furthermore, in the Italians studied, the absence of a polymorphic Pvu II cutting site (P1 allele) was found to be strongly associated with familial hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904255     DOI: 10.1161/01.atv.8.6.845

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  6 in total

1.  Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia.

Authors:  L A Salazar; M H Hirata; E C Quintão; R D Hirata
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  RFLPs of the LDL-receptor gene: their use in the diagnosis of FH and in evaluation of different levels of gene expression on normal subjects.

Authors:  S Bertolini; D A Coviello; P Masturzo; E Zucchetto; N Elicio; R Balestreri; G Orecchini; S Calandra; S Humphries
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

3.  A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a).

Authors:  I C Klausen; P S Hansen; L U Gerdes; N Rüdiger; N Gregersen; O Faergeman
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

4.  Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.

Authors:  C Bétard; A M Kessling; M Roy; A Chamberland; S Lussier-Cacan; J Davignon
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

5.  Use of three DNA polymorphisms of the LDL receptor gene in the diagnosis of familial hypercholesterolemia.

Authors:  A Daga; T Mattioni; R Balestreri; D A Coviello; G Corte; S Bertolini
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

6.  Association of Estrogen Receptor α Genes PvuII and XbaI Polymorphisms with Type 2 Diabetes Mellitus in the Inpatient Population of a Hospital in Southern Iran.

Authors:  Farzaneh Mohammadi; Mohammad Pourahmadi; Mohadeseh Mosalanejad; Houshang Jamali; Mohamed Amin Ghobadifar; Saeideh Erfanian
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.